The Asia Pacific immunohistochemistry market is projected to rise at 8.18% of CAGR during the forecasting years. The base year considered for the market study is 2017 and the forecasting years are from 2018 to 2026. Rising cancer incidence and growing popularity of POC testing are advancing the market in the APAC region.

ASIA PACIFIC IMMUNOHISTOCHEMISTRY MARKET FORECAST 2018-2026

Asia Pacific Immunohistochemistry Market by Products (Antibodies, Equipment, Reagents, Kits) by Applications (Diagnostics, Testing) by End Users (Hospitals and Diagnostic Laboratories, Research Institutes, Other End-users) & by Geography.

Request free sample

The Asia Pacific immunohistochemistry market is projected to rise at 8.18% of CAGR during the forecasting years. The base year considered for the market study is 2017 and the forecasting years are from 2018 to 2026. Rising cancer incidence and growing popularity of POC testing are advancing the market in the APAC region.

The immunohistochemistry market in Asia Pacific region is forecasted to evolve at the fastest growth rate. China, India, Japan, South Korea, Australia, and Rest of APAC are countries present in the Asia Pacific region. China is the most lucrative market for immunohistochemistry market. Academic research is on the constant upsurge in China which is bringing technological developments in the market. In addition, the Chinese government are taking well-funded & substantial precision medicine initiative to augment the growth of the market in the country. On the other hand, increasing geriatric dependence is the major factor for the growth of the market in India.

The top companies mentioned in the market report are Merck Millipore, Bio-Rad Laboratories Inc., Cell Signaling Technology Inc., Danaher Corporation, Histologix, F. Hoffmann-La Roche Ag, Siemens Ag Healthcare, Bio Sb, Biogenex, Thermo Fisher Scientific Inc., Agilent Technologies Inc., Abbott Laboratories, Abcam Plc, and Perkinelmer Inc.

 

To request a free sample copy of this report, please complete the form below:

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

    1. RESEARCH SCOPE
      • STUDY GOALS
      • SCOPE OF THE MARKET STUDY
      • WHO WILL FIND THIS REPORT USEFUL?
      • STUDY AND FORECASTING YEARS
    2. RESEARCH METHODOLOGY
      • SOURCES OF DATA
        • SECONDARY DATA
        • PRIMARY DATA
      • TOP DOWN APPROACH
      • BOTTOM-UP APPROACH
      • DATA TRIANGULATION
    3. EXECUTIVE SUMMARY
      • MARKET SUMMARY
      • KEY FINDINGS
        • REAGENTS PRODUCTS ARE GROWING AT A SIGNIFICANT RATE
        • DIAGNOSTICS IS MAJORLY USED APPLICATION IN THE MARKET
        • HOSPITALS AND DIAGNOSTIC LABORATORIES HOLDS THE LARGEST SHARE IN THE END-USERS MARKET
    1. MARKET DETERMINANTS
      • MARKET DRIVERS
        • RISING CANCER INCIDENCE
        • TECHNOLOGICAL EXPANSIONS IN IN-VITRO DIAGNOSTIC COMMERCE
        • INCREASING HEALTHCARE SPENDING
        • GROWING POPULARITY OF POC TESTING
      • MARKET RESTRAINTS
        • LIMITATIONS OF CLOSED SYSTEMS
        • PRESENCE OF AN UNDIAGNOSED POPULATION
      • MARKET OPPORTUNITIES
        • USE OF BIOMARKERS FOR DISEASE DIAGNOSIS AND INCREASING EFFICIENCY
        • PARADIGM SHIFT TOWARD PRECISION DIAGNOSIS THROUGH PERSONALIZED MEDICINE
        • ADVANCEMENTS IN TECHNOLOGIES
      • MARKET CHALLENGES
        • HIGH INITIAL INVESTMENT AND MAINTENANCE COST
        • STRINGENT REGULATION FOR APPROVAL OF DEVICES
        • PRICING PRESSURE COUPLED WITH LACK OF PRODUCT DIFFERENTIATION
    1. MARKET SEGMENTATION
      • MARKET BY PRODUCTS 2018-2026
        • ANTIBODIES
          • PRIMARY ANTIBODIES
          • SECONDARY ANTIBODIES
        • EQUIPMENT
          • SLIDE STAINING SYSTEMS
          • TISSUE MICROARRAYS
          • TISSUE PROCESSING SYSTEMS
          • SLIDE SCANNERS
          • OTHER EQUIPMENT’S
        • REAGENTS
          • HISTOLOGICAL STAINS
          • BLOCKING SERA AND REAGENTS
          • CHROMOGENIC SUBSTRATES
          • FIXATION REAGENTS
          • STABILIZERS
          • ORGANIC SOLVENTS
          • PROTEOLYTIC ENZYMES
          • DILUENTS
        • KITS
      • MARKET BY APPLICATIONS 2018-2026
        • DIAGNOSTICS
          • CANCER
          • INFECTIOUS DISEASES
          • CARDIOVASCULAR DISEASE
          • AUTOIMMUNE DISEASES
          • DIABETES MELLITUS
          • NEPHROLOGICAL DISEASES
        • DRUG TESTING
      • MARKET BY END USERS 2018-2026
        • HOSPITALS AND DIAGNOSTIC LABORATORIES
        • RESEARCH INSTITUTES
        • OTHER END USERS
    1. KEY ANALYTICS
      • IMMUNOHISTOCHEMISTRY ETYMOLOGY
      • VALUE CHAIN ANALYSIS
        • RAW MATERIAL SUPPLIERS
        • MANUFACTURERS
        • DISTRIBUTORS
        • END-USERS
      • OPPORTUNITY MATRIX
    2. GEOGRAPHICAL ANALYSIS
      • ASIA-PACIFIC
        • CHINA
        • INDIA
        • JAPAN
        • SOUTH KOREA
        • AUSTRALIA
        • REST OF APAC
    1. COMPANY PROFILES
      • ABBOTT LABORATORIES
        • COMPANY PROFILE
        • PRODUCT PORTFOLIO
        • SWOT ANALYSIS
        • STRATEGIC INITIATIVES
      • ABCAM PLC
        • COMPANY OVERVIEW
        • PRODUCT PORTFOLIO
        • STRATEGIC INITIATIVES
      • AGILENT TECHNOLOGIES, INC.
        • COMPANY OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVES
      • BIOGENEX
        • COMPANY OVERVIEW
        • PRODUCT PORTFOLIO
        • STRATEGIC INITIATIVES
      • BIO-RAD LABORATORIES, INC.
        • COMPANY OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVE
      • BIO SB
        • COMPANY OVERVIEW
        • PRODUCT PORTFOLIO
        • STRATEGIC INITIATIVES
      • CELL SIGNALING TECHNOLOGY, INC.
        • COMPANY OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVES
      • DANAHER CORPORATION
        • COMPANY OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVES
      • HOFFMANN-LA ROCHE AG
        • COMPANY OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS:
        • STRATEGIC INITIATIVES
      • HISTOLOGIX
        • COMPANY OVERVIEW
        • PRODUCT PORTFOLIO
      • MERCK MILLIPORE
        • COMPANY OVERVIEW
        • PRODUCT PORTFOLIO
        • STRATEGIC INITIATIVES
      • PERKINELMER, INC.
        • COMPANY OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVES
      • SIEMENS AG HEALTHCARE
        • COMPANY OVERVIEW
        • PRODUCT PORTFOLIO
        • SWOT ANALYSIS
        • STRATEGIC INITIATIVES
      • THERMO FISHER SCIENTIFIC INC.
        • COMPANY OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVES

     

    TABLE LIST

    TABLE 1       ASIA PACIFIC IMMUNOHISTOCHEMISTRY MARKET 2018-2026 ($ MILLION)

    TABLE 2       CANCER MARKERS USED IN DIAGNOSIS AND TREATMENT

    TABLE 3       POPULATION AGED 60 YEARS AND ABOVE

    TABLE 4       POPULATION AGED 80 YEARS AND ABOVE

    TABLE 5       ASIA PACIFIC IMMUNOHISTOCHEMISTRY MARKET BY PRODUCTS 2018-2026 ($ MILLION)

    TABLE 6       ASIA PACIFIC IMMUNOHISTOCHEMISTRY MARKET IN ANTIBODIES 2018-2026 ($ MILLION)

    TABLE 7       ASIA PACIFIC IMMUNOHISTOCHEMISTRY MARKET IN ANTIBODIES BY TYPES 2018-2026 ($ MILLION)

    TABLE 8       ASIA PACIFIC ANTIBODIES MARKET IN PRIMARY ANTIBODIES 2018-2026 ($ MILLION)

    TABLE 9       CLINICALLY IMPORTANT MONOCLONAL ANTIBODIES

    TABLE 10     ASIA PACIFIC ANTIBODIES MARKET IN SECONDARY ANTIBODIES GEOGRAPHY 2018-2026 ($ MILLION)

    TABLE 11     SECONDARY ANTIBODY SELECTION

    TABLE 12     ASIA PACIFIC IMMUNOHISTOCHEMISTRY MARKET IN EQUIPMENT 2018-2026 ($ MILLION)

    TABLE 13     ASIA PACIFIC IMMUNOHISTOCHEMISTRY MARKET IN EQUIPMENT BY TYPES 2018-2026 ($ MILLION)

    TABLE 14     ASIA PACIFIC EQUIPMENT MARKET IN SLIDE STAINING SYSTEMS 2018-2026 ($ MILLION)

    TABLE 15     ASIA PACIFIC EQUIPMENT MARKET IN TISSUE MICROARRAYS 2018-2026 ($ MILLION)

    TABLE 16     ASIA PACIFIC EQUIPMENT MARKET IN TISSUE PROCESSING SYSTEMS 2018-2026 ($ MILLION)

    TABLE 17     ASIA PACIFIC EQUIPMENT MARKET IN SLIDE SCANNERS 2018-2026 ($ MILLION)

    TABLE 18     ASIA PACIFIC EQUIPMENT MARKET IN OTHER EQUIPMENT’S 2018-2026 ($ MILLION)

    TABLE 19     ASIA PACIFIC IMMUNOHISTOCHEMISTRY MARKET IN REAGENTS 2018-2026 ($ MILLION)

    TABLE 20     ASIA PACIFIC IMMUNOHISTOCHEMISTRY MARKET IN REAGENTS BY TYPES 2018-2026 ($ MILLION)

    TABLE 21     ASIA PACIFIC REAGENTS MARKET IN HISTOLOGICAL STAINS 2018-2026 ($ MILLION)

    TABLE 22     HISTOLOGY STAINS AND ITS CATEGORIES

    TABLE 23     ASIA PACIFIC REAGENTS MARKET IN BLOCKING SERA AND REAGENTS 2018-2026 ($ MILLION)

    TABLE 24     ASIA PACIFIC REAGENTS MARKET IN CHROMOGENIC SUBSTRATES 2018-2026 ($ MILLION)

    TABLE 25     ASIA PACIFIC REAGENTS MARKET IN FIXATION REAGENTS 2018-2026 ($ MILLION)

    TABLE 26     COMMON FIXATIVES AND THEIR GENERAL TARGET ANTIGENS

    TABLE 27     ASIA PACIFIC REAGENTS MARKET IN STABILIZERS 2018-2026 ($ MILLION)

    TABLE 28     ASIA PACIFIC REAGENTS MARKET IN ORGANIC SOLVENTS 2018-2026 ($ MILLION)

    TABLE 29     ASIA PACIFIC REAGENTS MARKET IN PROTEOLYTIC ENZYMES 2018-2026 ($ MILLION)

    TABLE 30     ASIA PACIFIC REAGENTS MARKET IN DILUENTS 2018-2026 ($ MILLION)

    TABLE 31     ASIA PACIFIC IMMUNOHISTOCHEMISTRY MARKET IN KITS 2018-2026 ($ MILLION)

    TABLE 32     KIT COMPONENTS ARE AVAILABLE FOR IHC OPTIMIZATION

    TABLE 33     ASIA PACIFIC IMMUNOHISTOCHEMISTRY MARKET BY APPLICATION 2018-2026 ($ MILLION)

    TABLE 34     ASIA PACIFIC IMMUNOHISTOCHEMISTRY MARKET IN DIAGNOSTIC 2018-2026 ($ MILLION)

    TABLE 35     ASIA PACIFIC IMMUNOHISTOCHEMISTRY MARKET IN DIAGNOSTIC BY TYPES 2018-2026 ($ MILLION)

    TABLE 36     ASIA PACIFIC DIAGNOSTIC MARKET IN CANCER 2018-2026 ($ MILLION)

    TABLE 37     ASIA PACIFIC DIAGNOSTIC MARKET IN INFECTIOUS DISEASES 2018-2026 ($ MILLION)

    TABLE 38     ASIA PACIFIC DIAGNOSTIC MARKET IN CARDIOVASCULAR DISEASE 2018-2026 ($ MILLION)

    TABLE 39     ASIA PACIFIC DIAGNOSTIC MARKET IN AUTOIMMUNE DISEASES 2018-2026 ($ MILLION)

    TABLE 40     SELECTED INFECTIOUS ETIOLOGIES OF AUTOIMMUNE DISEASES

    TABLE 41     ASIA PACIFIC DIAGNOSTIC MARKET IN DIABETES MELLITUS 2018-2026 ($ MILLION)

    TABLE 42     ASIA PACIFIC DIAGNOSTIC MARKET IN NEPHROLOGICAL DISEASES 2018-2026 ($ MILLION)

    TABLE 43     ASIA PACIFIC IMMUNOHISTOCHEMISTRY MARKET IN DRUG TESTING 2018-2026 ($ MILLION)

    TABLE 44     ASIA PACIFIC IMMUNOHISTOCHEMISTRY MARKET BY END-USERS 2018-2026 ($ MILLION)

    TABLE 45     ASIA PACIFIC IMMUNOHISTOCHEMISTRY MARKET IN HOSPITALS AND DIAGNOSTIC LABORATORIES 2018-2026 ($ MILLION)

    TABLE 46     ASIA PACIFIC IMMUNOHISTOCHEMISTRY MARKET IN RESEARCH INSTITUTES 2018-2026 ($ MILLION)

    TABLE 47     CANCER RESEARCH PROGRAM

    TABLE 48     ASIA PACIFIC IMMUNOHISTOCHEMISTRY MARKET IN OTHER END-USERS 2018-2026 ($ MILLION)

    TABLE 49     IMMUNOHISTOCHEMISTRY USAGE IN FORENSIC PATHOLOGY

    TABLE 50     ASIA PACIFIC IMMUNOHISTOCHEMISTRY MARKET 2018-2026 ($ MILLION)

    TABLE 51     ASIA PACIFIC IMMUNOHISTOCHEMISTRY MARKET 2018-2026 ($ MILLION)

    TABLE 52     CANCER TYPES BASED ON INCIDENCE RATES (2016)

    TABLE 53     CANCER TYPES BASED ON MORTALITY RATES (2016)

    TABLE 54     ESTIMATED INCIDENCE OF ALL CANCERS COMBINED BY SEX (2017)

    TABLE 55     ESTIMATED COMMON CAUSES OF DEATH FOR CANCER (MALES 2017)

    TABLE 56     ESTIMATED COMMON CAUSES OF DEATH FOR CANCER BY SEX (FEMALES 2017)

     

    FIGURE LIST

    FIGURE 1     ASIA PACIFIC IMMUNOHISTOCHEMISTRY MARKET 2018-2026 ($ MILLION)

    FIGURE 2     ASIA PACIFIC IMMUNOHISTOCHEMISTRY MARKET IN ANTIBODIES 2018-2026 ($ MILLION)

    FIGURE 3     ASIA PACIFIC IMMUNOHISTOCHEMISTRY MARKET IN EQUIPMENT 2018-2026 ($ MILLION)

    FIGURE 4     ASIA PACIFIC IMMUNOHISTOCHEMISTRY MARKET IN REAGENTS 2018-2026 ($ MILLION)

    FIGURE 5     PHASES OF HISTOLOGICAL STAINING

    FIGURE 6     ASIA PACIFIC IMMUNOHISTOCHEMISTRY MARKET IN KITS 2018-2026 ($ MILLION)

    FIGURE 7     ASIA PACIFIC IMMUNOHISTOCHEMISTRY MARKET IN DIAGNOSTIC 2018-2026 ($ MILLION)

    FIGURE 8     ASIA PACIFIC IMMUNOHISTOCHEMISTRY MARKET IN DRUG TESTING 2018-2026 ($ MILLION)

    FIGURE 9     ASIA PACIFIC IMMUNOHISTOCHEMISTRY MARKET IN HOSPITALS AND DIAGNOSTIC LABORATORIES 2018-2026 ($ MILLION)

    FIGURE 10   ASIA PACIFIC IMMUNOHISTOCHEMISTRY MARKET IN RESEARCH INSTITUTES 2018-2026 ($ MILLION)

    FIGURE 11   ASIA PACIFIC IMMUNOHISTOCHEMISTRY MARKET IN OTHER END-USERS 2018-2026 ($ MILLION)

    FIGURE 12   HISTORY OF IMMUNOHISTOCHEMISTRY

    FIGURE 13   ASIA PACIFIC IMMUNOHISTOCHEMISTRY MARKET 2018-2026 ($ MILLION)

    FIGURE 14   CHINA IMMUNOHISTOCHEMISTRY MARKET 2018-2026 ($ MILLION)

    FIGURE 15   INDIA IMMUNOHISTOCHEMISTRY MARKET 2018-2026 ($ MILLION)

    FIGURE 16   JAPAN IMMUNOHISTOCHEMISTRY MARKET 2018-2026 ($ MILLION)

    FIGURE 17   SOUTH KOREA IMMUNOHISTOCHEMISTRY MARKET 2018-2026 ($ MILLION)

    FIGURE 18   AUSTRALIA IMMUNOHISTOCHEMISTRY MARKET 2018-2026 ($ MILLION)

    FIGURE 19   REST OF APAC IMMUNOHISTOCHEMISTRY MARKET 2018-2026 ($ MILLION)

    1. GEOGRAPHICAL ANALYSIS
      • ASIA-PACIFIC
        • CHINA
        • INDIA
        • JAPAN
        • SOUTH KOREA
        • AUSTRALIA
        • REST OF APAC
    1. MARKET SEGMENTATION
      • MARKET BY PRODUCTS 2018-2026
        • ANTIBODIES
          • PRIMARY ANTIBODIES
          • SECONDARY ANTIBODIES
        • EQUIPMENT
          • SLIDE STAINING SYSTEMS
          • TISSUE MICROARRAYS
          • TISSUE PROCESSING SYSTEMS
          • SLIDE SCANNERS
          • OTHER EQUIPMENT’S
        • REAGENTS
          • HISTOLOGICAL STAINS
          • BLOCKING SERA AND REAGENTS
          • CHROMOGENIC SUBSTRATES
          • FIXATION REAGENTS
          • STABILIZERS
          • ORGANIC SOLVENTS
          • PROTEOLYTIC ENZYMES
          • DILUENTS
        • KITS
      • MARKET BY APPLICATIONS 2018-2026
        • DIAGNOSTICS
          • CANCER
          • INFECTIOUS DISEASES
          • CARDIOVASCULAR DISEASE
          • AUTOIMMUNE DISEASES
          • DIABETES MELLITUS
          • NEPHROLOGICAL DISEASES
        • DRUG TESTING
      • MARKET BY END-USERS 2018-2026
        • HOSPITALS AND DIAGNOSTIC LABORATORIES
        • RESEARCH INSTITUTES
        • OTHER END-USERS

    To request a free sample copy of this report, please complete the form below :

    We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

      Choose License Type